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Abstract
Bacterial infections are a serious problem in aquaculture since they can result in massive
mortalities in farmed fish and invertebrates. Vibriosis is one of the most common diseases
in marine aquaculture hatcheries and its causative agents are bacteria of the genus Vibrio
mostly entering larval rearing water through live feeds, such as Artemia and rotifers. The
pathogenic Vibrio alginolyticus strain V1, isolated during a vibriosis outbreak in cultured
seabream, Sparus aurata, was used as host to isolate and characterize the two novel bacte-
riophages φSt2 and φGrn1 for phage therapy application. In vitro cell lysis experiments
were performed against the bacterial host V. alginolyticus strain V1 but also against 12 pre-
sumptive Vibrio strains originating from live prey Artemia salina cultures indicating the
strong lytic efficacy of the 2 phages. In vivo administration of the phage cocktail, φSt2 and
φGrn1, at MOI = 100 directly on live prey A. salina cultures, led to a 93% decrease of pre-
sumptive Vibrio population after 4 h of treatment. Current study suggests that administration
of φSt2 and φGrn1 to live preys could selectively reduce Vibrio load in fish hatcheries. Inno-
vative and environmental friendly solutions against bacterial diseases are more than neces-
sary and phage therapy is one of them.
Introduction
The intensification of aquaculture production has dramatically increased the incidences of
microbial diseases causing substantial economic losses to the industry. One of the biggest prob-
lems in intensive fish culture is the mass mortalities in fish larvae caused by bacterial infections
[1–3]. In marine aquaculture, vibrios are major pathogens causing vibriosis which is the most
common disease in marine fish and invertebrate hatcheries [3–7].
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Vibrio alginolyticus is a ubiquitous bacterium found in marine environment that has been
associated with disease in aquatic animals but also in humans, causing tissue damages in skin,
ear and internal organs [8–11].
V. alginolyticus is also one of the most common species found in marine hatchery water
[12,13] and it is considered as an important pathogen for marine organisms [14], especially by
being opportunistic invader of already damaged fish tissues [15]. There are several reports for V.
alginolyticus causing significant mortalities in cultured gilthead seabream, S. aurata, especially
during early life stages [16–20]. Larval enteropathy (LE) is the most important pathology affect-
ing this species at hatcheries, which is responsible for great reduction in survival rates. V. algino-
lyticus alone, or in synergy with other bacteria such as Aeromonas hydrophila, constitutes the
major causative agent of LE [19]. Apart from cultured gilthead seabream, V. alginolyticus infec-
tion has been recorded during early rearing stages (3 g) of sharpsnout seabream, Diplodus
puntazzo [21]. Mortality due to V. alginolyticus has also been recorded in ornamental fish [22–
24] and several invertebrates such as Penaeus monodon [25] andMacrobrachium rosenbergii
[26]. In aquaculture there is a general consensus that V. alginolyticus enters the system through
live prey (artemia and rotifers) which serve as vehicles for introducing the bacteria into the
hatchery tanks [27–29]. There are several studies demonstrating that Artemia nauplii are vectors
for potentially harmful bacteria such as Vibrio spp. [30]. V. alginolyticus has been reported as
the dominant member of the cultivable bacterial community of Artemia [13,29,31,32].
Disinfection techniques (filters, ozone, UV etc.) in marine hatcheries cannot offer a
completely bacteria—free environment [33] and may lead to microbial imbalance leaving envi-
ronmental niche wide open for the proliferation of opportunistic pathogens [34,35]. Adminis-
tration of antibiotics has traditionally been the most commonly applied strategy against
bacterial infections. Today, antibiotic usage is becoming increasingly obsolete in aquaculture as
many economically important pathogens evolve resistance, including strains belonging to the
genera Aeromonas and Vibrio [18,36–38]. Development of multi—drug resistant strains, dis-
turbance of natural microbiota, ecological and public health issues are some of the most impor-
tant problems caused by the excessive use of chemotherapy [39–41]. Thus, bacterial disease
outbreaks could be ideally managed by limiting or even excluding pathogenic bacteria, as Vib-
rio, from the system without affecting the beneficial microbes. In fragile systems like marine
hatcheries the use of bacteriophages, viruses that infect bacteria, is a promising alternative
since they can selectively remove their bacterial hosts, while leaving natural microbiota unaf-
fected [41,42]. Up to date, phage therapy has been applied in numerous cases of vibriosis
against many pathogenic Vibrio spp. such as V. harveyi, V. parahaemolyticus and V. anguil-
larum, with positive results [43–48].
The objective of this study is the isolation and characterization of lytic bacteriophages
against the dominant vibrios of the live feeds of a marine fish hatchery and the assessment of
their efficacy to reduce vibrio load in live feeds prior to their administration to fish larvae.
Materials and Methods
Bacterial strains and growth conditions
Vibrio alginolyticus, strain V1 was used as host for bacteriophage isolation. This strain was iso-
lated previously from a vibriosis episode in juvenile gilthead seabream, S. aurata and it has
already been fully sequenced [49]. Twenty-five different bacterial strains belonging to seven
Vibrio species (V. anguillarum, V. harveyi, V. alginolyticus, V. ordalii, V. parahaemolyticus, V.
splendidus and V. owensii) were used in the current study (Table 1). These bacteria were either
purchased from international collections, or belong to HCMR’s collection and include both
clinical and environmental isolates. V. splendidus strains were a kind offer from Dr. Frédérique
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Le Roux (Roscoff Marine Station). All bacterial species have been identified using biochemical
(BIOLOG GEN III) and/or molecular tools [50–52]. All bacterial strains were cultured in artifi-
cial sea water (23.4 gL-1NaCl, 24.7 gL-1 MgSO4 x 7H2O, 1.5 gL
-1KCl and 1.43 gL-1CaCl2 x
2H2O), supplemented with 1% tryptone (Difco) and 0.5% yeast extract (Difco) at 25°C with
reciprocal shaking [48].
Isolation and propagation of bacteriophages
Two novel bacteriophages were isolated from water samples collected from two locations of the
north coastline of Crete, Greece (35°20'16.2"N, 25°06'36.6"E and 35°20'05.3"N, 25°16'30.3"E)
through standard enrichment methodology [53]. No special permission was required for sam-
pling water. Briefly, samples were supplemented with 1% tryptone (Difco) and 0.5% yeast
extract (Difco) and then inoculated with bacterial host, V. alginolyticus strain V1. Samples
were incubated overnight at 25°C with reciprocal shaking, following centrifugation at 6,000 x g
for 10 min. Supernatants were filtered (0.22 μm) and 100 μL were plated by standard double-
layer agar method and incubated overnight at 25°C to detect and enumerate plaque forming
units (pfu). Isolated plaques were picked and purified by re-plating five times to ensure clonal
phage stocks. For phage propagation, 50 mL of a bacterial host liquid culture in early exponen-
tial phase (~108 cells mL-1) was infected at a multiplicity of infection (MOI) of 10 and incu-
bated overnight at 25°C with reciprocal shaking. After centrifugation of the cultures, the
supernatants were filtered (0.22μm), tittered and stored at 4°C.
Table 1. Bacterial strains of the genus Vibrio used in the current study. T: type strain.
# Strains Species Locality Type
1 V1 (host) V. alginolyticus Greece Clinical
2 DSMZ 2171 V. alginolyticus Japan Collection (T)
3 ValgHCMR V. alginolyticus Greece Clinical
4 R5 V. alginolyticus Greece Environmental
5 R6 V. alginolyticus Greece Environmental
6 E1 V. alginolyticus Greece Environmental
7 A1 V. alginolyticus Greece Environmental
8 V2 V. alginolyticus Greece Clinical
9 DSMZ 19623 V. harveyi USA Collection
10 VIB391 V. harveyi Thailand Clinical
11 Vh2 V. harveyi Greece Clinical
12 Vh4 V. harveyi Greece Clinical
13 Vh5 V. harveyi Greece Clinical
14 VhKar V. harveyi Greece Clinical
15 VhSerF V. harveyi Greece Clinical
16 VhNo22 V. harveyi Greece Clinical
17 Va5 V. splendidus Greece Clinical
18 3Z-31 V. splendidus France Clinical
19 3H2-4 V. splendidus France Clinical
20 DY05 V. owensii Australia Collection (T)
21 Vh3 V. parahaemolyticus Greece Clinical
22 PF4 V. anguillarum Chile Clinical
23 VaS V. anguillarum Greece Clinical
24 ATCC 19264 V. anguillarum Sweden Collection
25 ATCC 33509 V. ordalii USA Collection (T)
doi:10.1371/journal.pone.0151101.t001
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Host range and efficiency of plating (EOP)
Bacterial lawns of each bacterial strain tested were prepared on Petri dishes of artificial sea
water (23.4 gL-1NaCl, 24.7 gL-1 MgSO4 x 7H2O, 1.5 gL
-1KCl and 1.43 gL-1CaCl2 x 2H2O) sup-
plemented with 1% tryptone (Difco) and 0.5% yeast extract (Difco), and 20 μL drops of each
phage were added on them, following overnight incubation at 25°C. EOP assay was also per-
formed to obtain a quantitative measure of phage’s lytic activity and to assess possible “lysis
from without” phenomenon [54,55]. EOP was determined for each phage—sensitive bacterial
strain, by dividing the infectivity of phages vs tested strains to the infectivity of phages vs host
strain V1 [56].
Morphological characterization of bacteriophages
Virion morphology of isolated phages was observed by Transmission Electron Microscopy
(TEM). Samples were prepared on collodium copper grids, negatively contrasted with 2% ura-
nyl acetate, and examined using an electron microscope (JEOL JEM2100) at 80 kV and an
instrumental magnification of 120,000.
Viral whole genome extraction and RFLP analysis
Bacteriophages’ genome was extracted using phenol-chloroform protocol [48] and visualized
in agarose gel 0.4% at 30 mV compared to a high range genome size ladder (Thermo Scientific
GeneRuler High Range DNA Ladder). Restriction Fragment Length Polymorphism analysis
(RFLP) was performed using six different restriction enzymes HpaII, Sau3AI, HincII,HaeIII,
BgIII and BamHI, according the manufacturer’s instructions (Promega) for digesting phage
genome. The genome of the phages was tested for resistance against RNAse A (Qiagen) and
DNAse (Qiagen) treatment.
One step growth curve of the bacteriophages
Bacteriophages were added to 1mL host bacterial culture in early exponential phase, with
MOI = 0.01, following incubation at 25°C for 15 min and centrifugation at 6,000 x g for
10 min. Supernatant containing free phages was discarded whereas phages that managed to
attach to the bacteria during interaction time were pelleted on the bottom of the tube. Pellet
was suspended in 0.5 mL and then transferred in 20 mL fresh liquid medium. This moment
was considered as t = 0 and thereafter, 20 μL drops of serial dilutions were placed on Petri
dishes containing bacterial lawn of the host, every 10 min for total duration of 80 min. Phage
plaques were counted following overnight incubation at 25°C. The experiment was repeated
three times for each phage.
In vitro efficacy vs host strain V1
In vitro lysis assay was performed in sterile 96-well plates using a TECANmicroplate reader
(Infinite PRO 200) equipped with temperature control. Briefly, 24 wells were used per each
condition. Wells were loaded with 200 μL of freshly prepared culture of the host bacteria. The
plate was placed in the reader and incubated at 25°C with orbital shaking. Cultures were
infected at 3 different MOIs (1, 10 and 100 in sextuplicates) when the bacterial culture was at
the exponential phase. Twelve wells were not infected and served as control. The growth curve
of the cultures was monitored in real—time over 1000 min and OD560 measurements were
recorded every 20 min.
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In vitro efficacy vs presumptive vibrios from A. salina culture
The lytic effect of phages φGrn1 and φSt2 was also tested in vitro against bacterial isolates from
live feed A. salina culture, grown on the selective medium for Vibrio TCBS (Thiosulphate Cit-
rate Bile Salt). A sample from HCMR’s Artemia live feed culture was serially diluted on TCBS
and incubated at 25°C for 24 h. Twelve different single bacterial colonies covering the whole
range of various morphologies were picked and recultured twice on artificial sea water
(23.4 gL-1NaCl, 24.7 gL-1 MgSO4 x 7H2O, 1.5 gL
-1KCl and 1.43 gL-1CaCl2 x 2H2O), supple-
mented with 1% tryptone (Difco) and 0.5% yeast extract (Difco). Bacterial cultures of isolated
presumptive vibrios were infected in their early exponential phase by the mixture of φSt2 and
φGrn1 using a MOI = 100, with both phages’ titer being approximately the same. The experi-
ment was done as described previously for the host strain in a 96 –well plate for 850 min orga-
nized in triplicates per bacterium.
In vivo administration of φGrn1 and φSt2 in A. salina culture
The brine shrimp, Artemia is a zooplanktonic organism widely used as live feed. It can be
hatched within 24 hours from dormant cysts (batch culture) which can be easily distributed
and stored for prolonged periods of time [30]. The cultures of Artemia salina (SEP Art, INVE),
were obtained from the department of live feed cultures of the Hellenic Centre for Marine
Research.
The presumptive Vibrio load of the Artemia cultures had been estimated earlier to be
approximately 105 cfu mL-1. Six plastic containers were used, each containing 1L of A. salina
cultures supplied with intense aeration. The total presumptive Vibrio count in each container
was assessed at t0 = 0 h and at t1 = 4 h following serial dilutions of 1 mL samples and plating in
TCBS. Phage mixture of φGrn1 and φSt2 was directly administered at a MOI = 100. The exper-
iment was done in triplicates, phage treated vs untreated controls Artemia cultures.
Statistical analysis
Statistical analysis was performed to assess statistical significance of the difference between the
two groups (control and phage treated) of the in vivo experiment. A two—way ANOVA (factor
A: time, factor B: treatment, dependent variable: Vibrio population) was performed following
assessment of normality of the data distribution. All statistical analyses were performed using
SigmaPlot, version 13.0, Systat Software, Inc., San Jose, California, USA, www.sigmaplot.com.
Results
Isolation and characterization of bacteriophages φSt2 and φGrn1
Enrichment method was used to process 20 water samples. Two of the filtrates producing
zones of clearing were selected for purification and further characterization. Bacteriophages
φSt2 and φGrn1 were successfully isolated and purified after five—times plaque re-plating. The
presence of phages was confirmed by single negative colonies formation on the bacterial lawn.
The morphology of the virions of φSt2 and φGrn1 under TEM (Fig 1) classified them to
Myoviridae family. Both φGrn1 and φSt2 have elongated head and contractile tail. The head of
bacteriophage φSt2 was approximately 81 nm wide by 151 nm long and the tail was about 132
nm long with a diameter of 20 nm. In the case of bacteriophage φGrn1, the head was approxi-
mately 74 nm wide by 138 nm long and the tail was about 134 nm long with a diameter of 20
nm. Furthermore, both phages possessed a filamentous appendage on the top of the head as
observed under TEM examination (Fig 1). Both phages produced similar pinhead’s size clear
plaques on the host bacterial lawn.
Phage Therapy in Aquaculture
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Twenty-five bacterial strains were used to define the lytic spectrum of the novel phages φSt2
and φGrn1. Both phages presented the same host range infecting different strains of V. algino-
lyticus, one strain of V. harveyi and one of V. parahaemolyticus. On the contrary, none of them
was able to infect any V. anguillarum, V. ordalii, V. owensii and V. splendidus strains (Table 2).
The lytic activity of phages φSt2 and φGrn1 is evident in 40% (10 out of 25) of the bacterial
strains tested.
Both bacteriophages contain a double stranded DNA sensitive to DNAse and resistant to
RNAse A treatment.HpaII,HaeIII and BamHI did not digest the genomes of the phages (Fig
2). However, both phages’ genomes were digested by Sau3AI, HincII and BgIII indicating the
genetic differentiation of these phages (Fig 2). According to unpublished results about the
sequences of φSt2 and φGrn1 their genome sizes are 250,485 bp and 248,605 bp, respectively.
The replication parameters of these phages were determined by one step growth curves
showed in Fig 3. Both φSt2 and φGrn1 had an approximate latency time of 30 min. However,
their burst sizes were quite different since in the case of φSt2 it was 97 pfu / cell whereas in the
case of φGrn1 the burst size was 44 pfu / cell.
In vitro lytic effect on Vibrio strains
The lytic effect on the host bacteria was tested by infecting fresh cultures of V. alginolyticus
strain V1 at the early exponential phase (OD560 ~ 0.15) with φSt2 and φGrn1 separately. Lysis
was proportional to the MOI used with the lowest (MOI = 1) resulting to no effect and the
highest (MOI = 100) to almost complete inhibition of bacteria growth for the whole duration
of the experiment (1000 min). The response of the host was similar for both phages with high
reproducibility of the results among the replicates (Fig 4a and 4b).
The phages were tested in vitro against twelve bacterial isolates grown in TCBS originated
from live feed A. salina culture. A phage mixture of φSt2 and φGrn1 at MOI = 100 significantly
affected the growth of all twelve bacterial strains tested (Fig 5a–5l). In all cases, there was a
delay in the exponential phase and even when the cultures reached a plateau of growth, the
density of phage—treated bacteria was lower compared to their corresponding controls.
Fig 1. Transmission Electron Microscopy micrographs of φSt2 (left) and φGrn1 (right). Both phages have similar morphology and are classified at the
Myoviridae family. White arrows indicated the filamentous appendage which is present on both phages’ heads.
doi:10.1371/journal.pone.0151101.g001
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PLOS ONE | DOI:10.1371/journal.pone.0151101 March 7, 2016 6 / 18
In vivo efficacy of phages to control Vibrio load in A. salina culture
The effect of the phage mixture (φSt2 and φGrn1 at MOI = 100) was in vivo examined by direct
administration in live prey cultures, A. salina. At t0 = 0, the presumptive Vibrio count in TCBS
plates was 8.1 x 104± 2.7 x 104 cfu mL-1 for the control and 7.6 x 104± 0.6 x 104 cfu mL-1 for the
phage-treated cultures with no statistically significant difference (p: 0.782). After 4 h of incuba-
tion, presumptive Vibrio count did not change in the control cultures while it became signifi-
cantly lower in the phage treated ones (p< 0.05). Total Vibrio load in phage treated live prey
was 5.3 x 103±3.1 x 103 cfu mL-1, which is approximately 1.3 orders of magnitude or 93%
decrease of the initial total presumptive cultivable Vibrio load (Fig 6).
Discussion
Live feed organisms like Artemia are able to bio-accumulate bacteria from the water column
[57] acting as a vehicle for pathogen transfer into the hatchery facilities. Bacteriophage therapy
in such fragile systems can be a reasonable alternative for the control of microbial diseases and
for the prevention of multi—drug resistant bacteria spreading in aquaculture [58]. Since antibi-
otic resistance mechanisms are irrelevant to mechanisms of phage infection, phages could be
successfully employed even against antibiotic—resistant pathogens [59].
Table 2. Host range of phages φSt2 and φGrn1 against 25 bacterial strains from 7 different Vibrio species: V. anguillarum, V. ordalii, V. harveyi, V.
alginolyticus, V. parahaemolyticus, V. splendidus and V. owensii. Dark grey colour indicates clear lysis, light grey colour indicates turbid lysis and white
colour indicates no inhibition. EOP is expressed as: the fraction of phages’ infectivity vs tested strains to phages’ infectivity vs host strain.
Strains Species φSt2 φGrn1
V1 (host) V. alginolyticus 1,E+00 1,E+00
DSMZ 2171 V. alginolyticus 6,E-01 9,E-01
ValgHCMR V. alginolyticus 1,E-05 4,E-05
R5 V. alginolyticus 8,E-01 8,E-01
R6 V. alginolyticus 5,E-05 4,E-04
E1 V. alginolyticus 6,E-01 9,E-01
A1 V. alginolyticus 2,E+00 1,E+00
V2 V. alginolyticus 8,E-01 4,E-01
DSMZ 19623 V. harveyi 0 0
VIB391 V. harveyi 1,E-01 7,E-01
Vh2 V. harveyi 0 0
Vh4 V. harveyi 0 0
Vh5 V. harveyi 0 0
VhKar V. harveyi 0 0
VhSerF V. harveyi 0 0
VhNo22 V. harveyi 0 0
Va5 V. splendidus 0 0
3Z-31 V. splendidus 0 0
3H2-4 V. splendidus 0 0
DY05 V. owensii 0 0
Vh3 V. parahaemolyticus 9,E-02 1,E-02
PF4 V. anguillarum 0 0
VaS V. anguillarum 0 0
ATCC 19264 V. anguillarum 0 0
ATCC 33509 V. ordalii 0 0
doi:10.1371/journal.pone.0151101.t002
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In the current study, two novel bacteriophages φSt2 and φGrn1 were isolated and character-
ized. Both phages produced plaques with identical morphology in host bacterial lawn. Observa-
tion under TEM resulted in one common virion morphology, similar to the V. alginolyticus
phage φpp2 [60]; all three phages belong to Myoviridae family, but the sizes of φSt2 and φGrn1
virions were much larger than φpp2. Bacteriophage φSt2 is larger than φGrn1 in both head
length (151 nm vs 138 nm) and head width (81 nm vs 74 nm). However, both phages had the
same tail length and diameter. They are different from other V. alginolyticus phages described in
literature like φA318 and VAP11 which are classified as Podoviridae viruses with diameter of
head 50–55 nm and 60 nm, respectively [61,62]. The head—associated filamentous appendage
that was present on all virions’ heads under TEM, is not a common morphological feature of
bacteriophages. However, similar devices have been recorded in Caulobacter crescentus phages
acting as tool for the initial attachment of the phages to the bacterial flagella of the host [63].
Whether this is also its function in the case of φSt2 and φGrn1 needs further investigation.
Host range results were identical for φSt2 and φGrn1 suggesting that they recognize identi-
cal or very similar structures as receptors in their host. Lytic activity of the phages was not lim-
ited to the host strain V1, since they were able to infect all 8 V. alginolyticus strains tested, as
Fig 2. Restriction endonuclease digestion profile of φSt2 and φGrn1 DNAs. 1: φSt2—HpaII, 2: φGrn1—
HpaII, 3: φSt2—Sau3AI, 4: φGrn1—Sau3AI, 5: φSt2—HincII, 6: φGrn1—HincII, 7: φSt2—HaeIII, 8: φGrn1—
HaeIII, 9: φSt2—BgIII, 10: φGrn1—BgIII, 11: φSt2—BamHI, 12: φGrn1—BamHI.
doi:10.1371/journal.pone.0151101.g002
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well as bacterial strains that belong to V. harveyi and V. parahaemolyticus species. In terms of
EOP, φSt2 and φGrn1 were almost equally efficient against all phage—sensitive bacterial
strains, producing plaques within one order of magnitude. According to host range and EOP
results, bacteriophages φSt2 and φGrn1 are broad host range phages, being able to infect in
total 10 out of the 25 strains (40%) tested. However, it should be mentioned that only one strain
for V. owensii and one strain of V. parahaemolyticus were examined against φSt2 and φGrn1,
thus, their lytic potential against these two harveyi clade bacterial species needs to be further
explored. The conservative nature of the structure of LPS phage receptors on the outer mem-
brane of many of Gram negative bacterial species, could be a possible explanation for this
broad lytic spectrum [64]. Further, genetic similarity of these bacterial species which belong to
the harveyi clade may also have contributed to this observation [65,66]. The best candidates for
phage therapy should be viruses able to lyse the majority of the bacterial target’s strains [67–
69]. Thus, φSt2 and φGrn1 are suggested as potential phage therapy candidates against infec-
tions caused by V. alginolyticus, since their lytic spectrum include all the V. alginolyticus strains
tested and even strains from other species. Moreover, these phages were able to affect the
growth of several strains isolated from an Artemia live feed system. It is known that several
marine phages can infect different strains of the same species or different closely related species
[53,70], however, specificity of phage-host interactions in marine waters is not fully elucidated
Fig 3. One step growth curve for bacteriophagesφSt2, latency time: 30 min, burst size: 97 phages per cell and φGrn1, latency time: 30 min and
burst size: 44 phages per cell. All values are means ± standard deviation of three independent experiments.
doi:10.1371/journal.pone.0151101.g003
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Fig 4. In vitro cell lysis experiment of phage (a) φSt2 and (b) φGrn1 vs host strain V. alginolyticus V1.
The conditions tested are: control (V1 strain without any phage addition) and 3 different MOI rates used for
infecting V1 (MOI = 1, MOI = 10, MOI = 100). The values are means ± standard deviation of the six replicates.
doi:10.1371/journal.pone.0151101.g004
Phage Therapy in Aquaculture
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Fig 5. (a) A1, (b) A2, (c) A3, (d) A4, € A5, (f) A6, (g) A7, (h) A8, (i) A9, (j) A10, (k) A11 and (l) A12. In vitro cell lysis experiment of phage mixture (φSt2 and
φGrn1) against 12 presumptive Vibrio strains (A1–A12) isolated from the live feed culture, A. salina. The values are means ± standard deviation of the three
replicates.
doi:10.1371/journal.pone.0151101.g005
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and needs further investigation [71]. Another similar case of broad host range Vibrio—phage
is φA318, isolated using V. alginolyticus host strain, able to infect several V. harveyi strains
[61]. Interestingly, φSt2 and φGrn1 had strong lytic effect also against V. alginolyticus type
strain DSM 2171, isolated in Japan from a spoiled horse mackerel responsible for food poison-
ing [72] expanding therefore their potential applications beyond aquaculture.
RFLP analysis showed that φSt2 and φGrn1 are two distinct phages. Three of the restriction
enzymes used could not digest the genome of these phages. Bacteriophages refractory to
restriction enzyme activity could be explained by several reasons. Among the most prevalent is
the natural loss of restriction sites during evolution [73] but also the integration of unusual
bases in the viral DNA [74,75]. More importantly, the expression of specific methyltransferase
genes that may be contained in the viral genome will cause epigenetic modifications on the
viral DNA affecting the restriction sites that endonucleases can recognize [76]. Comparative
genomic analysis of these phages would provide further insights to their genetic identity.
One step growth curves defined the biological parameters of φSt2 and φGrn1 replicative
cycle (latency time and burst size). Bacteriophages φSt2 and φGrn1 have similar and relatively
short latency time (in both cases about 30 min) compared to other phages [61,77], but differ
significantly in their burst sizes (φSt2, 97 phages per cell and φGrn1, 44 phages per cell). Phages
with short latency period and high burst size are the most appropriate candidates for phage
Fig 6. In vivo efficacy levels of phages φSt2 and φGrn1 administered directly in live feed cultures of A. salina. The values are means ± standard
deviation of triplicates experiment (p < 0.05).
doi:10.1371/journal.pone.0151101.g006
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therapy, however, usually high burst sizes are followed by a more extensive latency period [78].
Thus, φSt2 and φGrn1 can be considered as good candidates for phage therapy applications
since they have relatively short latent period and their burst size seems satisfactory apart from
their wide host range.
In vitro efficacy of φSt2 and φGrn1 showed that both phages were notably effective against
their bacterial host V. alginolyticus strain V1, at MOI = 10 and MOI = 100. On the contrary, at
MOI = 1 the effect of phages in the bacterial growth was minimum. According to the literature
high MOI rates, usually MOI = 100, are mostly used when phage therapy applied [44,79]. In
our case, when MOI = 100 was applied in vitro against V1, the bacterium was almost
completely eliminated after 100 min and did not recover until the end of the experiment (1000
min). Both φSt2 and φGrn1 exhibited a very similar but intense bactericidal activity. The use of
phage combination is proposed in order to avoid bacterial resistance against phage infection
[70], and there are several reports suggesting the use of phage cocktails to control vibriosis
[43,44,69].
Prior to the in vivo phage administration, a selection of 12 presumptive Vibrio isolates from
the A. salina culture were tested in vitro against the combined lytic activity of φSt2 and φGrn1.
All isolates showed a variable degree of sensitivity to the cocktail of φSt2 and φGrn1. Although
the strains were not identified to species level it was presumed that they were vibrios based on
their efficacy to grow on the Vibrio selective medium but also on colony morphology. These
strains were possibly closely related to V. alginolyticus since as stated earlier according to the
literature, this species is considered to be the most prevalent bacterial component in A. salina
cultures [13,31,32].
In vivo phage therapy application resulted in significant decrease of the presumptive Vibrio
load in phage treated live preys. The initial presumptive Vibrio load in phage treated Artemia
was decreased by 93% meaning that 93% less Vibrio will enter the hatchery system. Therefore,
a treatment with phages in the live feeds prior to their introduction in the hatchery system
could effectively reduce the Vibrio load in the larval rearing tanks. Controlling and reducing
vibrios in fish and invertebrates hatcheries is critical for the final survival and quality of the
produced larvae since the possibility for disease outbreak increases proportionally with the
increase of the pathogen load. Our experiment did not show a total elimination of Vibrio in the
live feed. Nevertheless, the reduction but not the complete eradication of the vibrios may also
be beneficial since at a later stage, the maturing fish immune system will be exposed to low lev-
els of bacteria helping the fish to develop immunity before their transfer to the open sea. From
a practical point of view there are unique advantages in the use of phages as a preventive mea-
sure against vibriosis. Firstly, phage treatment procedure requires a relatively short period of
time (4 h in our case), which offers the opportunity of disinfecting the live prey exactly before
its administration to the larvae in the hatchery. The latter is that Artemia is a batch culture and
as such, bacterial resistance development against phage infection is rather difficult. A phage
treatment protocol could be established on a regular basis for each growth cycle of Artemia and
phages should be added to the live prey 4 h before administration to the fish. Besides, the use of
phages against vibrios would specifically reduce the load of potentially pathogenic bacteria,
leaving other species unaltered. Numerous studies using bacteriophages as treatment agents,
verify that applications in many aquaculture systems have been successful against many patho-
genic bacteria such as V. harveyi, V. parahaemolyticus and V. anguillarum [43,46,48,58,68].
The apparent lytic nature of the phages (also confirmed by the initial genomic analysis not
presented here) is an advantage but also a prerequisite for safe phage therapy development
since proliferation of resistant bacteria is considered one of the main drawbacks in the use of
bacteriophages to control bacteria [80]. It is commonly accepted that bacteriophages are a key
factor to determine the bacterial populations in the environment [81,82]. Drawbacks and issues
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of concern are the eventual resistance development from bacteria against phage infection and
the possibility of prophage induction, mutations and horizontal gene transfer [59]. These are
events occurring naturally in the environment which however may be augmented and acceler-
ated with careless use of phages, however variation in phage cocktails has the potential to delay
or even inhibit the emergence of phage resistance [83,84].
Currently, it is commonly accepted that the need of an innovative and environmentally
friendly alternative to antibiotics has become more than necessary. Presence of bacteriophages
in environments where pathogenic bacteria occur should be seen as an opportunity that may
lead to the development of a successful innovative and environmentally friendly solution.
However, phage therapy should always be applied with great caution. We hope that further
knowledge of phage—bacterium interactions will contribute to our ability to handle our own
microbiota, when bacteriophages are used as biocontrol agents.
Conclusions
The newly isolated bacteriophages, φSt2 and φGrn1, are characterized by broad host range and
compelling biological attributes making them potential candidates for phage therapy applica-
tion. The positive results obtained by in vitro and in vivo trials, advocate to the fact that phage
therapy in aquaculture can be an alternative to antibiotics. Thus, φSt2 and φGrn1 can effec-
tively be used in the biological control of the Vibrio load in marine hatcheries, through of live
prey disinfection.
Next step will be the analysis of the full genome sequencing of φSt2 and φGrn1 as well as
the further evaluation of the novel disinfection technique on the survival of fish larvae in a con-
trolled experiment.
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